← FDA Drug Approvals (Drugs@FDA)
UBROGEPANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMACEUTICALS (USA) INC. · Approved 2026-05-14
Drug application
- FDA Application #
ANDA218662- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- UBROGEPANT
- Generic name
- Ubrogepant
- Active ingredients
- UBROGEPANT
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- ZYDUS PHARMACEUTICALS (USA) INC.
- First approval
- 2026-05-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown